OppenheimerFunds’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$585K	Sell	4,026 -3,163	-44%	-$416K	﹤0.01%	1304
2018 Q4	$814K	Buy	7,189 +2,761	+62%	+$346K	﹤0.01%	1139
2018 Q3	$596K	Sell	4,428 -533	-11%	-$65.8K	﹤0.01%	1365
2018 Q2	$557K	Sell	4,961 -262	-5%	-$28.3K	﹤0.01%	1378
2018 Q1	$558K	Buy	5,223 +250	+5%	+$26.9K	﹤0.01%	1356
2017 Q4	$544K	Sell	4,973 -152,831	-97%	-$16.6M	﹤0.01%	1468
2017 Q3	$17M	Buy	157,804 +152,875	+3,102%	+$15.7M	0.02%	629
2017 Q2	$499K	Buy	4,929 +216	+5%	+$19.9K	﹤0.01%	1503
2017 Q1	$424K	Buy	4,713 +394	+9%	+$33.5K	﹤0.01%	1561
2016 Q4	$329K	Sell	4,319 -532,540	-99%	-$40.4M	﹤0.01%	1567
2016 Q3	$44.7M	Buy	536,859 +457,265	+574%	+$38.3M	0.06%	356
2016 Q2	$6.56M	Buy	+79,594	New	+$6.56M	0.01%	775
2016 Q1	–	Sell	-2,790	Closed	-$224K	–	1698
2015 Q4	$224K	Buy	+2,790	New	+$201K	﹤0.01%	1621